SOX9 and prostate cancer: ZBTB7A physically interacts with SOX9 and functionally antagonizes its transcriptional activity on key target genes; ZBTB7A inactivation determines Rib downregulation, bypass of PTEN loss-induced cellular senescence and invasive prostate cancer [628].